Jazz Pharmaceuticals
JAZZ
#1695
Rank
NZ$21.55 B
Marketcap
NZ$343.57
Share price
-0.15%
Change (1 day)
70.34%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -NZ$1.03 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are NZ$4.26 Billion. a decrease over its 2024 earnings that were of NZ$0.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$1.07 Billion-233.49%
2024 NZ$0.79 B57.87%
2023 NZ$0.50 B-179.92%
2022 -NZ$0.64 Billion230.37%
2021 -NZ$0.2 Billion-141.02%
2020 NZ$0.46 B-39.45%
2019 NZ$0.76 B-14.2%
2018 NZ$0.89 B20.03%
2017 NZ$0.74 B-17.15%
2016 NZ$0.90 B22.14%
2015 NZ$0.73 B187.64%
2014 NZ$0.25 B-50.79%
2013 NZ$0.52 B73.63%
2012 NZ$0.30 B41.69%
2011 NZ$0.21 B116.61%
2010 NZ$97.94 M262.77%
2009 NZ$26.99 M-111.33%
2008 -NZ$0.24 Billion1.31%
2007 -NZ$0.24 Billion77.8%
2006 -NZ$0.14 Billion36.59%
2005 -NZ$96.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.71 B-2,704.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
NZ$3.55 B-433.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-NZ$4.06 Billion 280.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
NZ$3.64 B-442.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel